ARCHIVES

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Cancer An Alteration In Gene Expression, Not Change In Structure, Tulane Biologist Reports

March 27, 1981

Guest Editorial: A Near-Term Solution: NCI And COG Agree on Plan to Maintain Enrollment

May 23, 2014

NCI Considers Seeking New Study Section For Clinical Research, Or Expansion Of E2

November 23, 1990

Committee Drafts QRA Definition

November 19, 1982

DCE Proposes AIDS-Cancer Registry For Funding Through $2 Mil. Contract

April 9, 1993

The Cancer Letter takes summer publication break, back Sept. 12.

August 8, 2003